Lupin submits #Marketing Authorization Application for Etanercept B#iOSimilar in #Europe

Lupin submits #Marketing Authorization Application for Etanercept B#iOSimilar in #Europe



Pharma major Lupin announced on Friday that its Marketing Authorization Application (MAA) for a biosimilar of Etanercept has been accepted for review by the European Medicines Agency (EMA). The indications targeted for approval are Rheumatoid Arthritis (RA …